Press Releases

UPDATE - New York City Icahn School of Medicine at Mount Sinai and Renowned Global Researcher Dr. Hurd, Select MediPharm Labs to Support 500 Patient Major Clinical Study And “CBD International Consortium” to Develop Treatment of Opioid Addiction

May 23, 2019

MediPharm Labs Australia Awarded Cannabis Manufacturing Licence From Office of Drug Control – Establishes Asia-Pacific Foothold

May 21, 2019

MediPharm Labs Announces Addition to $1.2B MJ ETFMG Alternative Harvest ETF (USA)

May 21, 2019

Emerald Health Therapeutics Introduces Unique Premium CBD Oil SYNC 25 to British Columbia Recreational Marketplace

May 17, 2019

MediPharm Labs Signs Committed Term Sheet for $20 Million Debt Facility With Schedule 1 Bank

May 15, 2019

Cronos Group and MediPharm Labs Enter $30 Million Multi-Year Private Label Cannabis Concentrate Supply Agreement with Potential to Increase to $60 Million

May 14, 2019

MediPharm Labs Announces Q1 2019 Revenue of $22 Million and Adjusted EBITDA of $4.3 Million

May 10, 2019

MediPharm Labs Sets Date to Release First Quarter 2019 Financial Results

May 8, 2019

MediPharm Labs Announces Upgrade to the OTCQX Best Market in the U.S. Under Symbol “MEDIF”

May 2, 2019

MediPharm Labs Appoints Renowned Medical Expert and Pharmaceutical Researcher Dr. Paul Tam to its Board of Directors

May 1, 2019